These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 38418351)
1. Mitochondrial K Yin XM; Song YY; Jiang WY; Zhang HT; Chen JW; Murao K; Han MX; Sun WP; Zhang GX Nutr Metab Cardiovasc Dis; 2024 Jun; 34(6):1571-1580. PubMed ID: 38418351 [TBL] [Abstract][Full Text] [Related]
2. Deacetylation mimetic mutation of mitochondrial SOD2 attenuates ANG II-induced hypertension by protecting against oxidative stress and inflammation. Dikalova A; Ao M; Tkachuk L; Dikalov S Am J Physiol Heart Circ Physiol; 2024 Aug; 327(2):H433-H443. PubMed ID: 38904850 [TBL] [Abstract][Full Text] [Related]
3. Deletion of vascular thromboxane A Braun H; Hauke M; Petermann M; Eckenstaler R; Ripperger A; Schwedhelm E; Ludwig-Kraus B; Bernhard Kraus F; Jalal Ahmed Shawon M; Dubourg V; Zernecke A; Schreier B; Gekle M; Benndorf RA Biochem Pharmacol; 2024 Jan; 219():115916. PubMed ID: 37979705 [TBL] [Abstract][Full Text] [Related]
4. Comparison of angiotensin-(1-7), losartan and their combination on atherosclerotic plaque formation in apolipoprotein E knockout mice. Yang J; Sun Y; Dong M; Yang X; Meng X; Niu R; Guan J; Zhang Y; Zhang C Atherosclerosis; 2015 Jun; 240(2):544-9. PubMed ID: 25957120 [TBL] [Abstract][Full Text] [Related]
5. Angiotensin-(1-7)-induced Mas receptor activation attenuates atherosclerosis through a nitric oxide-dependent mechanism in apolipoproteinE-KO mice. Yang G; Istas G; Höges S; Yakoub M; Hendgen-Cotta U; Rassaf T; Rodriguez-Mateos A; Hering L; Grandoch M; Mergia E; Rump LC; Stegbauer J Pflugers Arch; 2018 Apr; 470(4):661-667. PubMed ID: 29352340 [TBL] [Abstract][Full Text] [Related]
6. Elevated systemic TGF-beta impairs aortic vasomotor function through activation of NADPH oxidase-driven superoxide production and leads to hypertension, myocardial remodeling, and increased plaque formation in apoE(-/-) mice. Buday A; Orsy P; Godó M; Mózes M; Kökény G; Lacza Z; Koller A; Ungvári Z; Gross ML; Benyó Z; Hamar P Am J Physiol Heart Circ Physiol; 2010 Aug; 299(2):H386-95. PubMed ID: 20511416 [TBL] [Abstract][Full Text] [Related]
7. Effects of 3-methyladenine, an autophagy inhibitor, on the elevated blood pressure and arterial dysfunction of angiotensin II-induced hypertensive mice. Kwon Y; Haam CE; Byeon S; Choi SK; Lee YH Biomed Pharmacother; 2022 Oct; 154():113588. PubMed ID: 35994821 [TBL] [Abstract][Full Text] [Related]
8. ANG II infusion promotes abdominal aortic aneurysms independent of increased blood pressure in hypercholesterolemic mice. Cassis LA; Gupte M; Thayer S; Zhang X; Charnigo R; Howatt DA; Rateri DL; Daugherty A Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1660-5. PubMed ID: 19252100 [TBL] [Abstract][Full Text] [Related]
9. Role of Menkes ATPase in angiotensin II-induced hypertension: a key modulator for extracellular superoxide dismutase function. Qin Z; Gongora MC; Ozumi K; Itoh S; Akram K; Ushio-Fukai M; Harrison DG; Fukai T Hypertension; 2008 Nov; 52(5):945-51. PubMed ID: 18768397 [TBL] [Abstract][Full Text] [Related]
10. Role of copper transport protein antioxidant 1 in angiotensin II-induced hypertension: a key regulator of extracellular superoxide dismutase. Ozumi K; Sudhahar V; Kim HW; Chen GF; Kohno T; Finney L; Vogt S; McKinney RD; Ushio-Fukai M; Fukai T Hypertension; 2012 Aug; 60(2):476-86. PubMed ID: 22753205 [TBL] [Abstract][Full Text] [Related]
11. Interleukin-12p35 knockout promotes macrophage differentiation, aggravates vascular dysfunction, and elevates blood pressure in angiotensin II-infused mice. Ye J; Que B; Huang Y; Lin Y; Chen J; Liu L; Shi Y; Wang Y; Wang M; Zeng T; Wang Z; Hu H; Xu Y; Shi L; Ye D; Liu J; Jiang H; Wan J; Ji Q Cardiovasc Res; 2019 May; 115(6):1102-1113. PubMed ID: 30395167 [TBL] [Abstract][Full Text] [Related]
12. Activation of angiotensin II type 1 receptor-associated protein exerts an inhibitory effect on vascular hypertrophy and oxidative stress in angiotensin II-mediated hypertension. Wakui H; Dejima T; Tamura K; Uneda K; Azuma K; Maeda A; Ohsawa M; Kanaoka T; Azushima K; Kobayashi R; Matsuda M; Yamashita A; Umemura S Cardiovasc Res; 2013 Dec; 100(3):511-9. PubMed ID: 24189624 [TBL] [Abstract][Full Text] [Related]
13. Vasoprotective and atheroprotective effects of angiotensin (1-7) in apolipoprotein E-deficient mice. Tesanovic S; Vinh A; Gaspari TA; Casley D; Widdop RE Arterioscler Thromb Vasc Biol; 2010 Aug; 30(8):1606-13. PubMed ID: 20448208 [TBL] [Abstract][Full Text] [Related]
14. Mitochondrial KATP channel involvement in angiotensin II-induced autophagy in vascular smooth muscle cells. Yu KY; Wang YP; Wang LH; Jian Y; Zhao XD; Chen JW; Murao K; Zhu W; Dong L; Wang GQ; Zhang GX Basic Res Cardiol; 2014 Jul; 109(4):416. PubMed ID: 24847907 [TBL] [Abstract][Full Text] [Related]
20. Context-dependent effects of SOCS3 in angiotensin II-induced vascular dysfunction and hypertension in mice: mechanisms and role of bone marrow-derived cells. Li Y; Kinzenbaw DA; Modrick ML; Pewe LL; Faraci FM Am J Physiol Heart Circ Physiol; 2016 Jul; 311(1):H146-56. PubMed ID: 27106041 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]